Mercury Laboratories Limited Share Price

Mercury Laboratories Limited Share Price

BSE: 538964
|
Pharmaceuticals
₹ 835.00
+₹27.25 (3.37%)
1D
Last updated 24 Jul, 2026, 13:28 IST

Mercury Laboratories Limited Share Price Today

As of 25 Jul 2026, Mercury Laboratories Limited share price is ₹835.00. The stock opened at ₹835.00, compared to its previous close of ₹807.75. During today's trading session, Mercury Laboratories Limited share price moved in the range of ₹835.00 to ₹835.00, with an average price of ₹835.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹620.55 and a high of ₹976.00.

₹835.00
3.37% up today
₹835.00
1D LOW
1D HIGH

Mercury Laboratories Limited Returns Calculator

Circuit
L
H
₹646.20
₹969.30
52-week
L
H
₹620.55
₹976.00
Mkt Cap Cr
100.20
P/E
20.73
P/B
1.73
ROE
8.32%
D/E
0.15
ROCE
10.75%
Div. Yield
0.42%
EPS(TTM)
40.28
Turnover
1.13
EV/EBITDA
9.35
Net Margin
0.00%
Op. Margin
0.00%
ROA
6.12%
Quick Ratio
0.00
Curr. Ratio
4.37
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Mercury Labs has not beaten FD return of 7%
Step 2 of 5
Valuation
Expensive
Mercury Labs PE is significantly higher than its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,65,711.0036.735.0514.85%0.5518.72%18.850.91%0.5610.90
Divis Laboratories1,93,860.0061.369.4016.19%0.0021.00%9.430.50%0.5898.19
Torrent Pharmaceuticals1,92,687.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,12,593.0033.553.2711.27%0.0014.95%423.360.93%0.4443.52
Zydus Lifesciences1,11,082.0017.393.2319.69%0.3520.30%3.700.11%0.3935.38
Lupin1,09,553.0019.834.7127.01%0.0327.44%3.510.78%0.61129.18
Mankind Pharma1,05,607.001.050.1212.65%0.4212.97%5.050.05%0.5449.37
Dr. Reddy's Laboratories97,364.9030.582.5611.07%0.1812.54%377.960.69%0.4138.68
Aurobindo Pharma88,508.4025.272.349.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs84,727.3060.2610.1018.21%0.4016.70%97.210.12%0.6413.72

Mercury Laboratories Limited Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹75.10₹75.56₹75.33₹57.92
Other Income₹1.07₹1.09₹1.72₹0.82
Total Revenue₹76.17₹76.65₹77.05₹58.74
Total Expenses₹71.51₹69.73₹69.61₹53.83
Profit Before Tax₹4.66₹6.92₹7.44₹5.03
Tax₹1.52₹1.27₹1.87₹1.47
Profit After Tax₹3.14₹5.65₹5.58₹3.56
EPS - Basic₹26.21₹47.12₹46.49₹29.68
EPS - Diluted₹26.21₹47.12₹46.49₹29.68

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹4.66₹6.92₹7.44₹5.03
Income before WC changes₹8.14₹10.12₹10.29₹7.91
Change in Assets-₹5.77₹0.40-₹6.11₹3.85
Change in Liabilities₹4.03-₹1.04-₹0.63-₹4.66
Change in WC-₹1.75-₹0.64-₹6.73-₹0.80
Cash flow from Operations₹4.00₹8.23₹2.45₹5.19
Cash flow from Investing-₹9.04-₹6.27-₹1.06-₹1.89
Cash flow from Financing-₹0.99-₹1.04-₹1.01-₹1.23
Total Cash Flow-₹6.03₹0.91₹0.38₹2.07
Cash (Start of the year)₹8.23₹7.32₹6.93₹4.87
Cash (End of the year)₹2.19₹8.23₹7.32₹6.93

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹34.16₹28.12₹24.71₹27.21
Current Assets₹40.08₹39.84₹39.46₹35.22
Total Assets₹74.24₹67.96₹64.16₹62.43
Current Liabilities₹15.08₹12.63₹14.18₹15.75
Net Current Asset₹25.00₹27.20₹25.28₹19.47
Non-Current Liabilities₹5.59₹4.49₹4.36₹6.38
Equity Capital₹53.57₹50.84₹45.63₹40.31
Total Equity & Liabilities₹74.24₹67.96₹64.16₹62.43
* All values are in INR Crore
Qty
Bid
1
835
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 1
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
0
Neutral
6
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
53.24
Neutral
ATR (14)
42.65
Neutral
STOCH(9,6)
50.41
Neutral
STOCH RSI (14)
32.58
Neutral
ADX(9)
17.18
Bullish
UO(9)
37.66
Neutral
ROC(12)
3.99
Bullish
WillR(14)
-49.59
Neutral
Period
Simple value
Exponential vaue
5D
840.8
833.92
10D
833.08
831.67
20D
820.03
821.99
50D
796.37
804.36
100D
788.52
799.99

About Mercury Laboratories Limited

Mercury Laboratories Limited Share Price
ISIN
INE947G01011
Sector Market Cap
₹ 100.2 Cr

Mercury Laboratories Limited is an India-based pharmaceutical company. The Company operates through the Pharmaceuticals Products segment. It is engaged in the manufacturing and export of a range of pharmaceutical items. The products of the Company are in the segment of gynecology and pediatrics. Its products include antibiotic, antifungal, and antiviral formulations; anti-inflammatory formulations; antimalarial formulations; digestive formulations; hypoglycemic formulations; multivitamin formulations; central nervous system formulations; gynec formulations; CVS formulations; cough and cold formulations; and miscellaneous formulations, and innovative products. Its antibiotic, antifungal, and antiviral formulations include azithromycin tablets, azithromycin dispersible tablets, griseofulvin tablets, metronidazole tablets, and others. Its anti-inflammatory formulations include dexamethasone tablets, glucosamine sulphate tablets, dexamethasone sodium phosphate injection, and others.

Mercury Laboratories Limited Financial Highlights

  • Revenue: Mercury Laboratories Limited reported revenue of ₹77.90 crore in FY26 vs ₹76.17 crore in FY25. It showed an increase of 2.27% on a yearly basis.
  • Operating Profit: Mercury Laboratories Limited reported an operating profit of ₹6.64 crore in FY26 vs ₹4.66 crore in FY25. It showed an increase of 42.49% on a year-on-year basis.
  • Net Profit: Mercury Laboratories Limited reported a net profit of ₹4.83 crore in FY26 vs ₹3.14 crore in FY25. It showed an increase of 53.82% on a yearly basis.

Mercury Laboratories Limited Quarterly Result Highlights

  • Mercury Laboratories Limited reported revenue of ₹21.11 crore in Mar 2026, compared with ₹18.66 crore in Dec 2025, representing an increase of 13.13% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported an operating profit of ₹1.74 crore in Mar 2026, compared with ₹1.43 crore in Dec 2025, representing an increase of 21.68% on a quarter-on-quarter (QoQ) basis.
  • Mercury Laboratories Limited reported a profit of ₹1.23 crore in Mar 2026, compared with ₹1.00 crore in Dec 2025, reflecting an increase of 23.00% on a QoQ basis.
  • The earnings per share (EPS) of Mercury Laboratories Limited stood at ₹26.21 during Mar 2026.
Know more
Promoters
73.66%
FII
0.00%
Other DII
0.00%
Retail and other
26.34%
Mutual funds
0.00%
Foreign institutions - FII
Compare against other stocks
Mercury Laboratories Limited Share Price
Mercury Laboratories Limited
Pharmaceuticals
Add Stock
Add Another

FAQs on Mercury Laboratories Limited Share Price